Susan Hilsenbeck
Susan Galloway Hilsenbeck is an American biostatistician whose research interests include biomarkers and the applications of biostatistics in cancer research. She is a professor in the Baylor College of Medicine, where she directs the Quantitative Sciences Share Resource in the Dan L. Duncan Comprehensive Cancer Center.Hilsenbeck earned her Ph.D. in 1990, at the University of Miami. Her dissertation, ''Acquisition and use of information on data quality in large population-based tumor registries'', was supervised by Charles Kurucz. She was elected as a Fellow of the American Statistical Association in 2011.
Her hobbies include scuba diving and quilting. Her quilts have been featured in the books ''Amish Quilts, The Adventure Continues'' (2013) and ''Quarantine Quilts: Creativity in the Midst of Chaos'' (2021). Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Susan G. Hilsenbeck', query time: 0.03s
Refine Results
-
1
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth by Jing Qian, Yanxia Ma, William M. Tahaney, Cassandra L. Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Susan G. Hilsenbeck, Michelle I. Savage, Brent D. G. Page, Abhijit Mazumdar, Powel H. Brown
Published 2024-03-01
Article -
2
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth by Jing Qian, Yanxia Ma, William M. Tahaney, Cassandra L. Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Susan G. Hilsenbeck, Michelle I. Savage, Brent D. G. Page, Abhijit Mazumdar, Powel H. Brown
Published 2024-02-01
Article -
3
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy by Svasti Haricharan, Jie Dong, Sarah Hein, Jay P Reddy, Zhijun Du, Michael Toneff, Kimberly Holloway, Susan G Hilsenbeck, Shixia Huang, Rachel Atkinson, Wendy Woodward, Sonali Jindal, Virginia F Borges, Carolina Gutierrez, Hong Zhang, Pepper J Schedin, C Kent Osborne, David J Tweardy, Yi Li
Published 2013-12-01
Article -
4
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models by Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea, Tamika Mitchell, Tao Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S. Lalani, Chandandeep Nagi, Susan G. Hilsenbeck, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff
Published 2021-05-01
Article -
5
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer by Gloria V. Echeverria, Shirong Cai, Yizheng Tu, Jiansu Shao, Emily Powell, Abena B. Redwood, Yan Jiang, Aaron McCoy, Amanda L. Rinkenbaugh, Rosanna Lau, Alexander J. Trevarton, Chunxiao Fu, Rebekah Gould, Elizabeth E. Ravenberg, Lei Huo, Rosalind Candelaria, Lumarie Santiago, Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Wei T. Yang, Jason B. White, Jeffrey T. Chang, Stacy L. Moulder, W. Fraser Symmans, Susan G. Hilsenbeck, Helen Piwnica-Worms
Published 2023-01-01
Article -
6
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach by Varduhi Petrosyan, Lacey E. Dobrolecki, Lillian Thistlethwaite, Alaina N. Lewis, Christina Sallas, Ramakrishnan R. Srinivasan, Jonathan T. Lei, Vladimir Kovacevic, Predrag Obradovic, Matthew J. Ellis, C. Kent Osborne, Mothaffar F. Rimawi, Anne Pavlick, Maryam Nemati Shafaee, Heidi Dowst, Antrix Jain, Alexander B. Saltzman, Anna Malovannaya, Elisabetta Marangoni, Alana L. Welm, Bryan E. Welm, Shunqiang Li, Gerburg M. Wulf, Olmo Sonzogni, Chen Huang, Suhas Vasaikar, Susan G. Hilsenbeck, Bing Zhang, Aleksandar Milosavljevic, Michael T. Lewis
Published 2023-01-01
Article